Atara Biotherapeutics (ATRA) Stock Price, Quote, News & History | Benzinga

Atara Biotherapeutics Inc (ATRA) Stock Price, Quote, News & History

ATRANASDAQ

Trade with Public

Trade with Public

$8.45

0.202.42%

At close: Aug 6, 5:00 PM EST

$8.20

-0.05-0.61%

Pre-Market: 7:09 AM EST

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Compare Stock Report

Key Statistics

Open

-

Close

$8.45

Volume / Avg.

349.00 / 1.38M

Day Range

- - -

52 Wk Range

3.92 - 19.15

Market Cap

$73.88M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

43

Short Interest

9.13%

Days to Cover

6.24

Recent Atara Biotherapeutics, Inc. News

Why Lisata Therapeutics Shares Are Trading Higher By Over 20%; Here Are 20 Stocks Moving Premarket

Lisata Therapeutics (LSTA) surged 20.3% to $5.03 in pre-market trading after agreeing to be taken private by Kuva Labs for $5.00 per share + $1.00 CVR.

Avi Kapoor

Atara's Outlook As Ebvallo Hits Second FDA CRL

biotechanalyzer

Gold Rises Sharply; Lyra Therapeutics Shares Plunge

Avi Kapoor

FDA Rejects Atara Biotherapeutics' Cell Therapy Again, Stock Sinks

Atara Biotherapeutics stock drops on FDA rejection of EBVALLO BLA for serious post-transplant complication. FDA raises new concerns.

Vandana Singh

US Stocks Lower; Dow Tumbles Over 250 Points

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-25.88M

Investing Cash Flow (TTM)

949.00K

Financing Cash Flow (TTM)

19.30M

Free Cash Flow (TTM)

-25.88M

Capital Expenditure (TTM)

-

Net Change in Cash (TTM)

-5.63M

Analyst Trends and Forecast

1

May

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.3

Hold

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$77.60M

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

4.92

PB Ratio (TTM)

-

Earnings Yield % (TTM)

-14.49%

Earnings Yield % (FWD)

-17.22%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

-$4.14

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

$0

Total Cash

$8.36M

Debt to Equity

-

Issuance of Debt (TTM)

$0

Repayment of Debt (TTM)

$0

Key Statistics

Open

-

Close

$8.45

Volume / Avg.

349.00 / 1.38M

Day Range

- - -

52 Wk Range

3.92 - 19.15

Market Cap

$73.88M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

43

Short Interest

9.13%

Days to Cover

6.24

About

Sector

Health Care

Industry

Biotechnology

Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and man...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy Atara Biotherapeutics (ATRA) stock?

A

You can purchase shares of Atara Biotherapeutics (NASDAQ:ATRA) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Atara Biotherapeutics (ATRA) competitors?

A

Other companies in Atara Biotherapeutics’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).

Q

What is the forecast, or price target, for Atara Biotherapeutics (ATRA) stock?

A

Atara Biotherapeutics has a consensus price target of $13.59.

Q

What is the current price for Atara Biotherapeutics (ATRA)?

A

The stock price for Atara Biotherapeutics (NASDAQ: ATRA) is $8.2 last updated August 10, 2026 at 7:02 AM EDT.

Q

Does Atara Biotherapeutics (ATRA) pay a dividend?

A

There are no upcoming dividends for Atara Biotherapeutics.

Q

When is Atara Biotherapeutics (NASDAQ:ATRA) reporting earnings?

A

Atara Biotherapeutics does not have any upcoming earnings scheduled.

Q

Is Atara Biotherapeutics (ATRA) going to split?

A

There is no upcoming split for Atara Biotherapeutics.

Q

What sector and industry does Atara Biotherapeutics (ATRA) operate in?

A

Atara Biotherapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.